Total revenue for the quarter was $792 million, an increase of 14 percent (13 percent on a constant currency basis, 12 percent on an organic constant currency basis) compared with the third quarter of 2020.

U.S. Markets revenue was $498 million, an increase of 14 percent (12 percent on an organic basis) compared with the third quarter of 2020.

  • Financial Services revenue was $278 million, an increase of 11 percent compared with the third quarter of 2020.
  • Emerging Verticals revenue, which includes Healthcare, Insurance and all other verticals, was $221 million, an increase of 17 percent (14 percent on an organic basis) compared with the third quarter of 2020.

Adjusted EBITDA was $210 million, an increase of 19 percent (19 percent on an organic basis) compared with the third quarter of 2020.

International revenue was $178 million, an increase of 23 percent (18 percent on a constant currency basis) compared with the third quarter of 2020.

  • Canada revenue was $31 million, an increase of 10 percent (4 percent on a constant currency basis) compared with the third quarter of 2020.
  • Latin America revenue was $27 million, an increase of 23 percent (22 percent on a constant currency basis) compared with the third quarter of 2020.
  • United Kingdom revenue was $55 million, an increase of 24 percent (16 percent on a constant currency basis) compared with the third quarter of 2020.
  • Africa revenue was $15 million, an increase of 23 percent (8 percent on a constant currency basis) compared with the third quarter of 2020.
  • India revenue was $35 million, an increase of 44 percent (44 percent on a constant currency basis) compared with the third quarter of 2020.
  • Asia Pacific revenue was $16 million, an increase of 10 percent (11 percent on a constant currency basis) compared with the third quarter of 2020.

Adjusted EBITDA was $78 million, an increase of 37 percent (31 percent on a constant currency basis) compared with the third quarter of 2020.

Consumer Interactive revenue was $135 million, an increase of 3 percent compared with the third quarter of 2020.
Adjusted EBITDA was $69 million, an increase of 4 percent compared with the third quarter of 2020.

Recently Announced Transactions

On September 13, 2021, we announced our agreement to acquire Neustar, Inc. (“Neustar”) for $3.1 billion in cash, subject to customary purchase price adjustments. We intend to finance the acquisition through a combination of debt financing and cash on hand, and have entered into a debt commitment letter which provides for a senior secured term loan facility in an aggregate principal amount of up to $3.1 billion. We expect the acquisition to close in the fourth quarter of 2021, subject to the satisfaction of customary closing conditions and regulatory approvals. For additional information on our acquisition of Neustar, refer to our Press Release dated September 13, 2021, which is available on our Investor Relations website at https://investors.transunion.com/.

Today, we announced our agreement to acquire Sontiq, Inc. (“Sontiq”) for $638 million in cash, subject to customary purchase price adjustments. We intend to finance the acquisition through a combination of debt financing and cash on hand, and have entered into a debt commitment letter which provides for a new secured term loan facility in an aggregate principal amount of up to $640 million. We expect the acquisition to close in the fourth quarter of 2021, subject to the satisfaction of customary closing conditions and regulatory approvals. For additional information on our acquisition of Sontiq, refer to our Press Release dated October 26, 2021, which is available on our Investor Relations website at https://investors.transunion.com/.

Today, we also announced our agreement to sell our Healthcare business for $1.735 billion in cash, subject to customary purchase price adjustments. We intend to use the net proceeds from this sale to prepay debt and for other general corporate purposes as permitted under the Senior Secured Credit Facilities. We are targeting closing in the fourth quarter of 2021, subject to the satisfaction of customary closing conditions and regulatory approvals. For additional information on the divestment of our Healthcare business, refer to our Press Release dated October 26, 2021, which is available on our Investor Relations website at https://investors.transunion.com/.

Source:  TransUnion Earnings Release